Navigation Links
Cell study finds receptor can fight tamoxifen-resistant breast cancer cells
Date:4/27/2010

A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor (FXR) a nuclear receptor found mainly in the liver is found in breast cancer tissue. Although previous research showed that FXR can slow proliferation of breast cancer cells, it was not known whether it could do the same with tamoxifen-resistant cells.

The research is part of an effort to overcome tamoxifen resistance in breast cancer patients who are good candidates for tamoxifen treatment, but who either do not respond to the drug or who develop resistance over time. These findings suggest that FXR, when activated by chenodeoxycholic acid (a bile acid) or GW4064 (a synthetic), can slow the proliferation of breast cancer cells that are tamoxifen resistant, said one of the study's authors, Cinzia Giordano.

Giordano, Donatella Vizza, Salvatore Panza, Ines Barone, Daniela Bonofiglio, Suzanne A. Fuqua, Stefania Catalano and Sebastiano And carried out the study, "Activated farnesoid X receptor inhibits growth of tamoxifen resistant breast cancer cells." The researchers are from the University of Calabria in Italy, except Dr Fuqua, who is with Baylor College of Medicine in Houston.

The study will be presented at the Experimental Biology 2010 conference on Saturday, April 24 and again on Tuesday, April 27. The American Society for Investigative Pathology is sponsoring the sessions. The conference takes place in Anaheim April 24-28.

Maintaining tamoxifen sensitivity is key

Tamoxifen is an effective breast cancer treatment for patients who are estrogen receptor positive the majority of breast cancer patients. Breast cancer cells, which need estrogen to grow, have estrogen receptors to allow them to take in estrogen. Tamoxifen interferes with the cancer cells' ability to get estrogen and in the process inhib
'/>"/>

Contact: Donna Krupa
media@faseb.org
714-765-2012
Federation of American Societies for Experimental Biology
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Study examines global availability of treatment involving transplantation of blood stem cells
2. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
3. Comparative-effectiveness study confirms new treatment for diabetic macular edema
4. CureTogether Announces Online Autism Treatment Study
5. LA BioMed awarded research grant to study HIV prevention gel
6. Study Makes Strides in Understanding Ovarian Cancer
7. Brown Rice Tied to Better Heart Health in Study
8. NIH study confirms location of stem cells near cartilage-rich regions in bones
9. Immune cells predict success of head and neck cancer treatment, U-M study finds
10. Noncardiac Chest Pain May Warrant More Management: Study
11. SGIC Study Finds Drivers Are Losing Their Cool At School
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 iGearUnlimited.com ... of an iPad case for students. The answers didn't surprise ... iPad from daily use and abuse, 2. Not too bulky ... and kids' backpack, 3. Built-in kick-stand that works in both ... need show as a trackable barcodes on each case, 5. ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... MessageSolution, an industry leader in enterprise-class information archiving, ... Enterprise eDiscovery Platform 7.0, the latest release in ... all facets of the legal discovery lifecycle. MessageSolution ... in Los Angeles CA. , As the first ...
(Date:5/20/2013)... Columbus, Ohio (PRWEB) May 20, 2013 Can you ... you start to tell a joke? , Would you like to ... Do you sometimes feel like your funny bone is missing? , ... a zinger...until 2 hours later?     , If this sounds like you, ... can locate and develop their sense of humor; and even learn ...
(Date:5/20/2013)... Townsend Security, a leading authority in ... Alliance Key Manager hardware security module (HSM) will ... for TrueCrypt for Windows . Enterprises can now ... TrueCrypt for data protection. , “Townsend Security is ... for TrueCrypt encryption. Today's announcement reflects our strong ...
(Date:5/19/2013)... California has one of the largest pool of job ... that comprehensive background checks are playing an important role in ... records can paint an accurate portrait of a person, ... DUI arrests, speeding offenses, and traffic violations to their name. ... experience 4SafeDrivers.com, a new online service which allows users to ...
Breaking Medicine News(10 mins):Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 2Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 2Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 3Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2
... (SAN FRANCISCO, December 6, 2008) Four studies highlighting ... sickle cell disease will be presented today at the ... in San Francisco, CA. , Results from a ... improve endothelial dysfunction, a malfunction in the inner lining ...
... The use of dexamethasone early in the treatment of children ... cancer, may help reduce the risk of relapse according to ... December 6, at 2:00 p.m., during the 50th Annual Meeting ... Additional research will be featured at the press conference that ...
... 2008) A study assessing the quality of care for ... settings will be presented at a press conference on Saturday, ... of the American Society of Hematology in San Francisco, CA. ... risk in children with sickle cell disease, as well as ...
... 6, 2008) Four studies that highlight significant advances ... forms of thrombocytopenia, a group of bleeding disorders characterized ... will be presented in a press conference on Saturday, ... Meeting of the American Society of Hematology in San ...
... a call from a biotech lab in Korea. He was told ... clone of a pet dog, his beloved family mutt, Missy. Now ... healthy puppy living the good life in Mill Valley, California. “Not ... coat feels the same, and she has some of the same ...
... for Leadership on Right to Health , ... Boston (Vocus) December 5, ... community members and experts join for a landmark town meeting titled ,HIV/AIDS ... event, which commemorates World AIDS Day and the 60th anniversary of the ...
Cached Medicine News:Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 2Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 3Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 4Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 5Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 6Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 7Health News:Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma 2Health News:Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma 3Health News:Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma 4Health News:Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma 5Health News:Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma 6Health News:Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma 7Health News:Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma 8Health News:Studies examine quality of care for hospitalized sickle cell disease patients 2Health News:Studies examine quality of care for hospitalized sickle cell disease patients 3Health News:Studies examine quality of care for hospitalized sickle cell disease patients 4Health News:Studies examine quality of care for hospitalized sickle cell disease patients 5Health News:Studies examine quality of care for hospitalized sickle cell disease patients 6Health News:Studies examine quality of care for hospitalized sickle cell disease patients 7Health News:Studies examine quality of care for hospitalized sickle cell disease patients 8Health News:Novel therapeutic approaches may improve patient outcomes in several platelet disorders 2Health News:Novel therapeutic approaches may improve patient outcomes in several platelet disorders 3Health News:Novel therapeutic approaches may improve patient outcomes in several platelet disorders 4Health News:Novel therapeutic approaches may improve patient outcomes in several platelet disorders 5Health News:Novel therapeutic approaches may improve patient outcomes in several platelet disorders 6Health News:Novel therapeutic approaches may improve patient outcomes in several platelet disorders 7Health News:Novel therapeutic approaches may improve patient outcomes in several platelet disorders 8Health News:Cloned Canine Celebrates Her 1st Birthday 2Health News:Community Unites for Physicians for Human Rights Town Meeting on Global AIDS and Human Rights on December 8 2Health News:Community Unites for Physicians for Human Rights Town Meeting on Global AIDS and Human Rights on December 8 3Health News:Community Unites for Physicians for Human Rights Town Meeting on Global AIDS and Human Rights on December 8 4Health News:Community Unites for Physicians for Human Rights Town Meeting on Global AIDS and Human Rights on December 8 5Health News:Community Unites for Physicians for Human Rights Town Meeting on Global AIDS and Human Rights on December 8 6
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... HILL, N.C. , May 17, 2013 /PRNewswire/ ... how organizations communicate internally. Faced with a constantly ... their strategies and tactics for communicating with internal ... effectiveness of all the strategies, tactics and tools ... In a new study, Best Practices, ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip.  Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22.  ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Delivers New Technology for Science to CYTO 2013 2
... CSA Medical, Inc., the leading developer of novel Spray ... inside the body, today announced that it has completed ... with the addition of a venture investment from Blue ... to address customer demand and support the launch of ...
... 2011 Boston Scientific Corporation (NYSE: BSX ... clinical follow-up study designed to evaluate its Adapt™ Monorail™ ... Embolic Protection System for treatment of carotid artery disease ... trial began in 2010 and has reached its enrollment ...
Cached Medicine Technology:CSA Medical Completes $12.6 Million Series A Financing With Additional Venture Investment From Blue Heron Capital 2Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 2Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 3Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 4
... the sounds you need to ... other body sounds while reducing ... Littmann Model 3000., ,With Ambient ... to 18 times amplification, and ...
CVC 9005 Hematocrit Calibration Verification Controls are materials used for verifying the calibration and linearity of hematocrit sensors in IRMA TRUpoint cartridges for systems using software versi...
... 823 is an assayed quality ... the performance of blood gas, ... instrumentation. It is available in ... analyzer performance at varying points ...
... QC 623 is an assayed quality control ... is available in four (4) levels for monitoring ... range. It may be used on multiple test ... and the Radiometer 600). QC623 is also for ...
Medicine Products: